JP2022544463A5 - - Google Patents

Info

Publication number
JP2022544463A5
JP2022544463A5 JP2022506360A JP2022506360A JP2022544463A5 JP 2022544463 A5 JP2022544463 A5 JP 2022544463A5 JP 2022506360 A JP2022506360 A JP 2022506360A JP 2022506360 A JP2022506360 A JP 2022506360A JP 2022544463 A5 JP2022544463 A5 JP 2022544463A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
years old
adult male
erectile dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506360A
Other languages
English (en)
Japanese (ja)
Other versions
JP7605825B2 (ja
JP2022544463A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072092 external-priority patent/WO2021023805A1/en
Publication of JP2022544463A publication Critical patent/JP2022544463A/ja
Publication of JP2022544463A5 publication Critical patent/JP2022544463A5/ja
Application granted granted Critical
Publication of JP7605825B2 publication Critical patent/JP7605825B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506360A 2019-08-06 2020-08-06 併用療法のための化合物 Active JP7605825B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19190224.6 2019-08-06
EP19190224 2019-08-06
PCT/EP2020/072092 WO2021023805A1 (en) 2019-08-06 2020-08-06 Compound for combination treatment

Publications (3)

Publication Number Publication Date
JP2022544463A JP2022544463A (ja) 2022-10-19
JP2022544463A5 true JP2022544463A5 (https=) 2023-08-15
JP7605825B2 JP7605825B2 (ja) 2024-12-24

Family

ID=67551141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506360A Active JP7605825B2 (ja) 2019-08-06 2020-08-06 併用療法のための化合物

Country Status (16)

Country Link
US (1) US20220288052A1 (https=)
EP (2) EP4009942B1 (https=)
JP (1) JP7605825B2 (https=)
KR (1) KR20220054593A (https=)
CN (1) CN114430679A (https=)
AU (1) AU2020326244B2 (https=)
BR (1) BR112022002169A2 (https=)
CA (1) CA3146837A1 (https=)
DK (1) DK4009942T3 (https=)
ES (1) ES2962648T3 (https=)
FI (1) FI4009942T3 (https=)
IL (1) IL290319B2 (https=)
MX (1) MX2022000356A (https=)
PL (1) PL4009942T3 (https=)
WO (1) WO2021023805A1 (https=)
ZA (1) ZA202200723B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4646204A1 (en) * 2023-01-03 2025-11-12 Initiator Pharma A/S Compound for treatment of erectile dysfunction
WO2025051846A1 (en) 2023-09-05 2025-03-13 Initiator Pharma A/S Compound for treatment of female sexual dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04012693A (es) * 2002-06-20 2005-03-23 Lundbeck & Co As H Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina.
RU2354377C2 (ru) * 2003-07-11 2009-05-10 Берингер Ингельхайм Ветмедика Гмбх Способ лечения или предупреждения заболеваний центральной нервной системы с использованием соединений, обладающих селективностью в отношении альфа-3-субъединицы бензодиазепинового рецептора
BRPI0515261A (pt) * 2004-09-30 2008-07-15 Neurosearch As composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso do composto quìmico ou de qualquer um de seus isÈmeros ou de qualquer mistura de seus isÈmeros, ou um sal farmaceuticamente aceitável do mesmo, e, método para o tratamento, a prevenção ou o alìvio de uma doença ou de um distúrbio ou de uma condição de um corpo de animal vivo
WO2008074798A1 (en) * 2006-12-20 2008-06-26 Neurosearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
BRPI0917802A2 (pt) * 2008-08-21 2016-03-01 Neurosearch As método para tratar um distúrbio de ansiedade, composição farmacêutica, uso do composto, uso de uma combinação, kit de partes, método para tratar, prevenir ou aliviar um distúrbio de ansiedade de um corpo de animal vivo, e, combinação
US20130040985A1 (en) 2010-01-29 2013-02-14 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Similar Documents

Publication Publication Date Title
JP7650929B2 (ja) 成人における焦点てんかんの処置のための合成経皮的カンナビジオール
CN115884761A (zh) 大麻素的透皮药物制剂
AU2016371598B2 (en) Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
JP2021080276A (ja) デクスメデトミジン製剤を使用する睡眠障害の予防または治療
US20200060992A1 (en) Therapeutical methods, formulations and nutraceutical formulations
JP2022544463A5 (https=)
CN118141791A (zh) 用于治疗周围神经痛的、至少包含阿米替林的局部药物组合物
CN107835695A (zh) 用于治疗自闭症的组合物和方法
CN105327349A (zh) Nmda受体拮抗剂的医药用途及其药物组合物
JP2016505050A5 (https=)
RU2008134143A (ru) Фармацевтическая композиция цитиколина, холина альфосцерата и l-карнитина (или ацетил-l-карнитина) для лечения и профилактики заболеваний центральной нервной системы и способ лечения
AU2013271841B2 (en) Method of prevention of neurological diseases
WO2019038586A1 (en) PHARMACEUTICAL COMPOSITION OF MELATONIN
IL272834B2 (en) Amantadine compositions, preparations thereof, and methods of use
ES2968345T3 (es) Combinaciones de oxicodona y palmitoiletanolamina de N-aciletanolamina para reducir los efectos secundarios asociados a los opioides
CN114288289A (zh) 具有镇痛和/或止痒功能的药物组合物及其应用
RU2013105513A (ru) Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи
SI2694065T1 (en) A composition for treating a disorder of hypoactive sexual desire
CN115835862A (zh) 治疗阿尔茨海默病的组合及其应用
JP7469841B2 (ja) 口内乾燥症の治療剤
US11607406B2 (en) Therapeutical methods, formulations and nutraceutical formulations
JPWO2014181724A1 (ja) 嚥下障害の治療薬
JP2023518430A5 (https=)
BE1009851A3 (fr) Composition pharmaceutique pour le traitement des cephalees et son utilisation.
ITUB20155024A1 (it) Nuova composizione nutraceutica, somministrabile per via orale, per la prevenzione o trattamento di stati infiammatori e dolorifici delle vie aeree superiori.